Recent studies suggest that TIM-3 may interact with ferroptosis signaling pathways, as chronic inflammation can induce senescence and ferroptosis in T cells, further compromising the immune response (131, 132)
That includes: Appropriate use of pharmacotherapies Metabolic and bariatric surgery when indicated Lifestyle intervention as a co-therapy, not an alternative and not a pathway to deprescribing Longitudinal, patient-centered care that addresses biology, function, and quality of life Recent FDA action regarding non-FDA-approved GLP-1 products is an important reminder that safety, evidence, and oversight matter: : Access matters
Deep vein thrombosis stood out
When combined with semaglutide, the gastric emptying delay is maintained but tolerability is similar to semaglutide alone
At TrimRx, we are more than just a provider of medications